Three-dimensional evaluation of palatal vault changes after unilateral posterior crossbite correction with quad helix or rapid maxillary expansion: A randomized controlled trial with 1-year follow-up
Related Experiment Video
Updated: May 6, 2026
Treatment of Facial Deformities using 3D Planning and Printing of Patient-Specific Implants
Published on: May 23, 2020
Stina Hansson1, Rune Lindsten2, Eva Josefsson2
1Department of Orthodontics, Postgraduate Dental Education Center, Örebro, Sweden and School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Objectives:
To compare the effects of quad helix (QH) anchored on permanent molars versus rapid maxillary expansion (RME) anchored on deciduous teeth on palatal morphology in early mixed dentition patients.
Trial Design:
A two-arm randomized controlled trial, together with a non-randomized normal bite data for comparison.
Methods:
Seventy-one patients (mean age: QH=9.3years; RME=9.4years) with unilateral posterior crossbite were analysed. The QH group (n=36) and RME group (n=35) were evaluated at baseline (T0), post-retention (T2), and one-year post-treatment (T3). A third age- and sex-matched control group (n=22; mean age=9.1years) served as a normative reference. Evaluated outcomes were 3D palatal measurements, as well as treatment success rate and total treatment duration.
Results:
Both treatment groups showed significant increases in palatal surface area, projection plane area, and volume from T0 to T3. The RME group experienced a greater increase in palatal surface area (7.0%) compared to the QH group (4.2%) over the same period (P=0.045). Palatal volume increased notably more in the RME group during active treatment (T0-T2), with an 11.2% gain versus 6.8% in the QH group (P=0.046). By T3, palatal vault dimensions had normalized in both groups compared to the control group. The RME group completed treatment 97days earlier than the QH group.
Conclusions:
Treatment with either QH or RME resulted in normalized palatal vaults compared to the control group. RME had a significantly shorter treatment time but achieved similar success in correcting posterior crossbite as QH. This trial was registered at ClinicalTrials.gov (ID NCT04458506) and Researchweb.org (project number 260581).
